JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | M. A., Sawsan | |
| dc.contributor.author | S., Hesham | |
| dc.contributor.author | N., Marianne | |
| dc.contributor.author | M. C., El-Maraghy | |
| dc.date.accessioned | 2020-02-09T08:26:22Z | |
| dc.date.available | 2020-02-09T08:26:22Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | References 1. Cutler AJ, Goldstein JM, Tumas JA (2002) Dosing and switching strategies for quetiapine fumarate. Clin Ther 24: 209-222. 2. Warawa EJ, Migler BM (1988) Novel dibenzothiazepine antipsychotic. U.S. Patent 4879288 A. 3. Sweetman S (2006) Matrindale, in the complete Drug Reference. Electronic Version. Pharmaceutical Press, London. 4. Cheer SM, Wagstaff AJ (2004) Quetiapine. A review of its use in the management of schizophrenia. CNS Drugs 18: 173-199. 5. Rajendraprasad N, Basavaiah K, Vinay KB (2010) Sensitive and selective extraction-free spectrophotometric determination of quetiapine fumarate in pharmaceuticals using two sulphonthalein dyes. Journal of Pre-Clinical and Clinical Research 4: 24-31. 6. Basavaiah K, Rajendraprasad N, Ramesh PJ, Vinay KB (2010) Sensitive ultraviolet spectrophotometric determination of quetiapine fumarate in pharmaceuticals. Thai J Pharm Sci 34: 146-154. 7. Rajendraprasad N, Basavaiah K, Vinay KB (2012) Extractive spectrophotometric determination of quetiapine fumarate in pharmaceuticals and spiked human urine. Croat Chem Acta 85: 9-17. 8. Bagade SB, Narkhede SP, Nikam DS, Sachde CK (2009) Development and validation of UV-Spectrophotometric method for determination of Quetiapine fumarate in two different dose tablets. Int J ChemTech Res 1: 898-904. 9. Hiraman BB, Sandip V, Lohiya TR, Umekar JM (2009) Spectrophotometric determination of an atypicalantipsychotic compound in pharmaceutical formulation. Int J ChemTech Res 1: 1153-1161. 10. Mahadik MV, Patre NG, Dhaneshwar SR (2009) Stability-indicating HPTLC method for quantitation of quetiapine fumarate in the pharmaceutical dosage form. Acta Chromatogr 21: 83-93. 11. Sathiya R, Krishnaraj K, Muralidharan S, Muruganantham N (2010) A simple and validated HPTLC method of evaluation for quetiapine fumarate in oral solid dosage form. Eurasian J Anal Chem 5: 246-253. 12. Dhandapani B, Somasundaram A, Raseed SH, Raja M, Dhanabal K (2009) Development and validation of HPTLC method for estimation of quetiapine in bulk drug and in tablet dosage form. Int J PharmTech Res 1: 139-141. Citation: Sawsan MA, Hesham S, Marianne N, El-Maraghy MC (2015) Validated HPLC and Thin Layer-Densitometric Methods for Determination of Quetiapine Fumarate in Presence of its Related Compounds. J Chromatogr Sep Tech 6: 275. doi:10.4172/2157-7064.1000279 Page 7 of 7 Volume 6 • Issue 5 • 1000279 J Chromatogr Sep Tech ISSN: 2157-7064 JCGST, an open access journal 13. Hillaert S, Snoeck L, Van den Bossche W (2004) Optimization and validation of a capillary zone electrophoretic method for the simultaneous analysis of four atypical antipsychotics. J Chromatogr A 1033: 357-362. 14. Ozkan SA, Dogan B, Uslu B (2006) Voltammetric Analysis of the Novel Atypical Antipsychotic Drug Quetiapine in Human Serum and Urine. Microchim Acta 153: 27-35. 15. Suneetha D, Rao A L (2010) A validated RP-HPLC method for the estimation of quetiapine in bulk and pharmaceutical formulations. E J Chem 7: 61-66. 16. Venkata BK, Battula SR, Dubey S (2013) Validation of quetiapine fumarate in pharmaceutical dosage by reverse-phase HPLC with internal standard method. J Chem 2013: 1-8. 17. Ingale PL, Dalvi SD, Gudi SV, Patil LD, Jadav DD, et al. (2013) Development of analytical method for determination of quetiapine fumarate in bulk & tablet dosage form. Der Pharma Chemica 5: 26-30. 18. Stolarczyk EU, Groman A, Kaczmarek S, Goebiewski P (2007) GC method for quantitative determination of residual 2-(2-chloroethoxy) ethanol (CEE) and N-methyl-2-pyrrolidinone (NMP) in quetiapine. Acta Pol Pharm 64: 187-189. 19. Raju IVS, Raghuram P, Sriramulu J (2009) Development and Validation of a New Analytical Method for the Determination of Related Components in Quetiapine Hemifumarate. Chromatographia 70: 545-550. 20. Belal F, Elbrashy A, Eid M, Nasr JJ (2008) Stability-indicating HPLC method for the determination of quetiapine: Application to tablets and human plasma. J Liq Chromatogr Related Technol 31: 1283-1298. 21. Rosa PCP, Pires IFR, Markman BEO, Perazzo FF (2013) Development and Validation of RP-HPLC Method for the Determination of Related Compounds in Quetiapine Hemifumarate Raw Material and Tablets. Journal of Applied Pharmaceutical Science 3: 6-15. 22. Krishna SR, Rao BM, Rao NS (2008) A validated stability indicating HPLC method for the determination of related substances in quetiapine fumarate. Rasayan jchem 1: 466-474. 23. Trivedi RK, Patel MC (2011) Development and validation of a stability indicating RP-UPLC method for determination of quetiapine in pharmaceutical dosage form. Sci Pharm 79: 97-111. 24. Dedania ZR, Sheth NR, Dedania RR (2013) Stability indicating highperformance thin-layer chromatographic determination of Quetiapine Fumarate. IJPSR 4: 2406-2414. 25. Stolarczyk EU, Kaczmarek L, Eksanow K, Kubiszewski M, Glice M, et al. (2009) Identification and characterization of potential impurities of quetiapine fumarate. Pharm Dev Technol 14: 27-37. 26. Mittapelli V, Vadali L, Sivalakshmi AD, Suryanarayana MV (2010) Identification, isolation, synthesis and characterization of principal oxidation impurities in Quetiapine. Rasayan Jchem 3: 677-680. 27. Food and Drug Administration, HHS (2003) International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice. Fed Regist 68: 64628-64629. 28. Bharathi Ch, Prabahar KJ, Prasad ChS, Srinivasa Rao M, Trinadhachary GN, et al. (2008) Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate. Pharmazie 63: 14-19. 29. ICH-International Conference on Harmonization, of Technical Requirements for registration of Pharmaceuticals for Human Use Topic Q2 (R1), (2005) Validation of Analytical Procedures: Text and Methodology, Geneva, Switzerland. | en_US |
| dc.identifier.other | https://doi.org/10.4172/2157-7064.1000279 | |
| dc.identifier.uri | https://t.ly/eWvdk | |
| dc.description | MSA Google Scholar | en_US |
| dc.description.abstract | Two chromatographic methods were developed for determination of quetiapine fumarate in presence of three related compounds; namely quetiapine N-oxide, des-ethanol quetiapine and quetiapine lactam, in pure form and pharmaceutical preparation. The first method depended on densitometric thin layer chromatography where the separation was achieved using silica gel 60F(254) plates as stationary phase and toluene:1,4-dioxane:dimethylamine (5:8:2, v/v/v) as a mobile phase. The second method utilized the reverse phase high performance liquid chromatographic technique, using C18 column and methanol: acetonitrile: phosphate buffer (pH 5.3) in a ratio (19:40:41, v/v/v) as a mobile phase. The flow rate was1 mL min-1 and UV-detection was at wavelength 220 nm. The validation parameters of the developed methods were calculated and the results obtained were statistically compared with those of the HPLC manufacturer method. | en_US |
| dc.description.sponsorship | OMICS Publishing Group | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | OMICS Publishing Group | en_US |
| dc.relation.ispartofseries | Journal of Chromatography & Separation Techniques;Volume: 6 Issue: 5 Pages: 1-7 | |
| dc.subject | University of HPLC; Quetiapine fumarate related compounds; Thin layer-densitometry | en_US |
| dc.title | Validated HPLC and Thin Layer-Densitometric Methods for Determination of Quetiapine Fumarate in Presence of its Related Compounds | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | https://doi.org/10.4172/2157-7064.1000279 | |
| dc.Affiliation | October University for modern sciences and Arts (MSA) |
